Become A Featured Company

Solis Tek Beats Out Competition in Cannabis Lighting Study

Ryan Allway

September 26th, 2017

Exclusive, News, Top News

There’s an estimated 1,600 to 2,200 wholesale cannabis cultivation businesses in the United States and over 1,000 dispensaries that grow their own cannabis, according to the Marijuana Business Factbook. Lighting systems are a vital part of any cultivation operation. They typically represent 20-30% of a commercial growers overall startup cost. Choosing the right lighting technology can impact the quality of a grow and the yield a cultivator gets out his or her garden.

According to an independent, third-party test of six cannabis-focused lighting companies, Solis Tek Inc.’s (OTCQB: SLTK) digital lighting solutions scored the highest in terms of overall value for cultivators. Analysts expect the U.S. cannabis industry to exceed $50 billion in size over the coming years, following the legalization of recreational marijuana in states like California and Nevada, which creates an enormous opportunity for lighting providers.

In this article, we will take a closer look at the independent study and why investors may want to consider the stock as a potential opportunity in the sector.

Light Laboratory Study

Light Laboratory Inc., an independent photometric testing laboratory, evaluated six different cannabis lighting providers to assess which offered the best overall value for cultivators. The study evaluated photosynthetic photon flux density (“PPFD”), which measures the quantity of light that arrives at the plant canopy and how plants “see” and “absorb” light. Higher readings translate to improved plant yields and lower costs for cultivators.

The study found that Solis Tek’s All-In-One A1 fixture had the best light output, providing a high-intensity and a more consistent footprint than competing options. In other words, the lighting solutions help commercial growers avoid hotspots and create a more even canopy, where no one plant grows taller and overshadows other plants. This helps anyone interested in growing cannabis plants create the best environment to increase yield.

Solis Tek’s unique four spectrum “light diet” targets specific growth cycles and replicates the different seasons of the year, where the plants make use of natural light in different ways. The company was the first cannabis lighting company to offer these features, which are now standard among many top commercial cannabis growers. These attributes help cultivators produce the highest quality crops at the lowest prices for consumers.

A Growing Opportunity

Solis Tek has experienced tremendous growth over the past several quarters as it capitalizes on increasing demand for its lighting solutions. In addition to its lighting products, the company recently expanded into the nutrients business with the launch of TERPENEZ™ in an effort to increase revenue and expand profit margins by upselling its existing customers. These efforts could unlock even more value for shareholders over the long-term and potentially improve its valuation multiples as it enters the $32 billion nutrient/additive sector.

Last quarter, the company reported revenue that increased 14.8% to $2,441,289 and a gross profit of $919,879. The company also introduced a new lighting controller at the end of the second quarter. These developments could support further revenue growth throughout the remainder of the year given the synergies with its existing customers and product lines.

“By leveraging the same client base as our existing lighting products, we expect the launch of the new nutrients division to drive significant revenue growth for Solis Tek, while expanding margins due to the increased efficiencies derived from utilizing existing sales and distribution channels,” says CEO Dennis Forchic. “Solis Tek remains ideally positioned to capitalize on the rapidly expanding legalization of medical and adult-use cannabis.”

Looking Ahead

Solis Tek Inc. (OTCQB: SLTK) represents a compelling investment opportunity within the burgeoning cannabis industry. With independent third party testing validating its lighting products, the company is well positioned to continue growing its lighting business while potentially benefiting from the addition of its nutrient product lineup. Investors may want to keep a close eye on the stock over the coming months given these catalysts.

For more information, visit the company’s website at www.solis-tek.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading